Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 21.5% | 24.9% | 28.0% | 27.1% | 28.1% | 30.4% | 29.6% | 24.7% | 18.9% | 23.1% | 11.3% | 11.2% | 12.0% | (1.0%) | 25.9% | 19.7% | 18.2% | 19.2% | 20.8% | 25.2% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 28.4%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Eli Lilly and Company have been 20.2% over the past three years, and 20.3% over the past five years.
As of today, Eli Lilly and Company's Return on Invested Capital (ROIC) is 28.4%, which is higher than industry median of 13.6%. It indicates that Eli Lilly and Company's Return on Invested Capital (ROIC) is Good.